These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 37984863)

  • 1. Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity.
    Li Y; Guo Y; Zhang K; Zhu R; Chen X; Zhang Z; Yang W
    Adv Sci (Weinh); 2024 Jan; 11(3):e2306580. PubMed ID: 37984863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
    Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selected Flavonols Targeting Cell Death Pathways in Cancer Therapy: The Latest Achievements in Research on Apoptosis, Autophagy, Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis.
    Wendlocha D; Kubina R; Krzykawski K; Mielczarek-Palacz A
    Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
    Gao W; Wang X; Zhou Y; Wang X; Yu Y
    Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
    Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
    J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy.
    Deng W; Shang H; Tong Y; Liu X; Huang Q; He Y; Wu J; Ba X; Chen Z; Chen Y; Tang K
    J Nanobiotechnology; 2024 Mar; 22(1):97. PubMed ID: 38454419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed Cell Death Tunes Tumor Immunity.
    Liu J; Hong M; Li Y; Chen D; Wu Y; Hu Y
    Front Immunol; 2022; 13():847345. PubMed ID: 35432318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment.
    Hsu SK; Li CY; Lin IL; Syue WJ; Chen YF; Cheng KC; Teng YN; Lin YH; Yen CH; Chiu CC
    Theranostics; 2021; 11(18):8813-8835. PubMed ID: 34522213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine.
    Wang X; Hua P; He C; Chen M
    Acta Pharm Sin B; 2022 Sep; 12(9):3567-3593. PubMed ID: 36176912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine-mediated regulated cell death in cancer immunotherapy.
    Sun Y; Lian T; Huang Q; Chang Y; Li Y; Guo X; Kong W; Yang Y; Zhang K; Wang P; Wang X
    J Control Release; 2023 Dec; 364():174-194. PubMed ID: 37871752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting regulated cell death in tumor nanomedicines.
    Zeng Q; Ma X; Song Y; Chen Q; Jiao Q; Zhou L
    Theranostics; 2022; 12(2):817-841. PubMed ID: 34976215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine-induced programmed cell death enhances tumor immunotherapy.
    Lu J; Tai Z; Wu J; Li L; Zhang T; Liu J; Zhu Q; Chen Z
    J Adv Res; 2024 Aug; 62():199-217. PubMed ID: 37743016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
    Woo Y; Lee HJ; Jung YM; Jung YJ
    Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis, necroptosis, and pyroptosis in cancer: Crucial cell death types in radiotherapy and post-radiotherapy immune activation.
    Wang Y; Wang Y; Pan J; Gan L; Xue J
    Radiother Oncol; 2023 Jul; 184():109689. PubMed ID: 37150447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Types of cell death and their relations to host immunological pathways.
    Lu KC; Tsai KW; Wang YK; Hu WC
    Aging (Albany NY); 2024 Aug; 16(15):11755-11768. PubMed ID: 39120579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferroptosis, pyroptosis and necroptosis in hepatocellular carcinoma immunotherapy: Mechanisms and immunologic landscape (Review).
    Liu RJ; Yu XD; Yan SS; Guo ZW; Zao XB; Zhang YS
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.
    Niu X; Chen L; Li Y; Hu Z; He F
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):273-285. PubMed ID: 35288298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The applications of nanozymes in cancer therapy: based on regulating pyroptosis, ferroptosis and autophagy of tumor cells.
    Zhang Y; Yu W; Chen M; Zhang B; Zhang L; Li P
    Nanoscale; 2023 Jul; 15(29):12137-12156. PubMed ID: 37377098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti-PD-1/PD-L1 cancer immunotherapy.
    Yu L; Huang K; Liao Y; Wang L; Sethi G; Ma Z
    Cell Prolif; 2024 Aug; 57(8):e13644. PubMed ID: 38594879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis in Inflammatory Bowel Disease, Colorectal Cancer, and Intestinal Injury.
    Zhou P; Zhang S; Wang M; Zhou J
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.